We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 7 start-ups with an aggregate funding of $195.5m. The average funding per company in this subset is $27.9m.
Last update to the database: Feb 18, 2025. See changelog.
Prokarium is a biopharmaceutical company focused on developing vaccination and cancer immunotherapy solutions based on synthetic biology.
6
Funding Rounds
$86.6m
Money raised
A computational immunology and vaccine development company based in Providence, Rhode Island. It was founded in 1998.
9
Funding Rounds
$4.3m
Money raised
A Canadian biotechnology company that develops specialty cell culture media, cell isolation systems and accessory products for life science research.
1
Funding Rounds
$15.0m
Money raised
ANA Therapeutics is a Foster City, California-based developer of a novel corona vaccine.
2
Funding Rounds
$5.0m
Money raised
Scienta Lab is a deep-tech company using artificial intelligence to transform pharmaceutical R&D in immunology and inflammation.
1
Funding Rounds
$4.3m
Money raised
Pipeline Therapeutics is a small Molecule for MS founded in 2017.
1
Funding Rounds
$80.0m
Money raised
Pascal Biosciences is a Vancouver-based company founded in 2013.
1
Funding Rounds
$343.8k
Money raised